News & Updates
Filter by Specialty:
Quercetin augments therapeutic benefit of antivirals for COVID-19
In patients hospitalized for severe COVID-19, adding the plant flavonoid quercetin to the antiviral drugs remdesivir or favipiravir reduced hospitalization period and levels of inflammatory markers related to the pathogenesis of SARS-CoV-2, thus preventing the progression of the disease into its critical phase, suggests an open-label study from Iran.
Quercetin augments therapeutic benefit of antivirals for COVID-19
03 Feb 2022
Early 3-day remdesivir course may prevent COVID-19 hospitalization, death
An early, 3-day regimen of remdesivir may prevent hospitalization and death in patients with COVID-19 who are at risk for disease progression, according to results of the PINETREE study.
Early 3-day remdesivir course may prevent COVID-19 hospitalization, death
26 Jan 2022
Which AECOPD patients are likely to test positive for flu?
In patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD), higher body temperature and heart rate, along with low white cell counts, are strong predictors of testing positive for influenza, according to a recent Singapore study.
